Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review.

Wilson, Lisa M; Baker, Kellan E; Sharma, Ritu; Dukhanin, Vadim; McArthur, Kristen; Robinson, Karen A

Wilson, Lisa M; Baker, Kellan E; Sharma, Ritu; Dukhanin, Vadim; McArthur, Kristen; Robinson, Karen A.

Afiliación

Wilson LM; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Baker KE; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Sharma R; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Dukhanin V; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
McArthur K; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Robinson KA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Int J Transgend Health ; 21(4): 391-402, 2020.

Article en En | MEDLINE | ID: mdl-34993517

Palabras clave

Antiandrogens; hyperprolactinemia; prolactin; prolactinomas; transgender women

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Int J Transgend Health Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google